IBDEI2FX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38982,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,38982,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,38982,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,38983,0)
 ;;=L20.9^^152^1990^87
 ;;^UTILITY(U,$J,358.3,38983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38983,1,3,0)
 ;;=3^Atopic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,38983,1,4,0)
 ;;=4^L20.9
 ;;^UTILITY(U,$J,358.3,38983,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,38984,0)
 ;;=L21.8^^152^1990^302
 ;;^UTILITY(U,$J,358.3,38984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38984,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,38984,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,38984,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,38985,0)
 ;;=L21.9^^152^1990^303
 ;;^UTILITY(U,$J,358.3,38985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38985,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,38985,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,38985,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,38986,0)
 ;;=L23.7^^152^1990^31
 ;;^UTILITY(U,$J,358.3,38986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38986,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,38986,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,38986,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,38987,0)
 ;;=L23.9^^152^1990^32
 ;;^UTILITY(U,$J,358.3,38987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38987,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,38987,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,38987,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,38988,0)
 ;;=L24.9^^152^1990^166
 ;;^UTILITY(U,$J,358.3,38988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38988,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,38988,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,38988,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,38989,0)
 ;;=L25.9^^152^1990^117
 ;;^UTILITY(U,$J,358.3,38989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38989,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,38989,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,38989,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,38990,0)
 ;;=L26.^^152^1990^151
 ;;^UTILITY(U,$J,358.3,38990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38990,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,38990,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,38990,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,38991,0)
 ;;=L27.0^^152^1990^305
 ;;^UTILITY(U,$J,358.3,38991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38991,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,38991,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,38991,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,38992,0)
 ;;=L27.1^^152^1990^306
 ;;^UTILITY(U,$J,358.3,38992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38992,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,38992,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,38992,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,38993,0)
 ;;=L29.0^^152^1990^290
 ;;^UTILITY(U,$J,358.3,38993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38993,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,38993,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,38993,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,38994,0)
 ;;=L29.9^^152^1990^291
 ;;^UTILITY(U,$J,358.3,38994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38994,1,3,0)
 ;;=3^Pruritus,Unspec
